3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
1
Hot Flashes
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
1
Interventions
Tamoxifen
7
Specimen Handling
7
exemestane
3
Letrozole
3
Anastrozole
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Biopsy
2
ruxolitinib
1
poly ICLC
1
fezolinetant
1
elacestrant
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Selective Estrogen Receptor Modulators
1
Radiotherapy
1
Radiation
1
Protons
1
Proton Therapy
1
Omacor
1
Neoadjuvant Therapy
1
Multicenter Studies as Topic
1
Metformin
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Magnetic Resonance Spectroscopy
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
fezolinetant
×
90 days
×
Clear all
NCT06617455
2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2
Terminated
9 enrolled